ASCO CERTIFIED Trademark

Trademark Overview


On Thursday, August 22, 2024, a trademark application was filed for ASCO CERTIFIED with the United States Patent and Trademark Office. The USPTO has given the ASCO CERTIFIED trademark a serial number of 98711524. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, March 5, 2025. This trademark is owned by American Society of Clinical Oncology, Inc.. The ASCO CERTIFIED trademark is filed in the Advertising, Business and Retail Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Business advisory services, consultancy, and information in the nature of quality improvement services, namely, assessment program for oncology practices for purposes of documenting concordance with quality measures, implementing best practices, and documenting improvement; business information services in the field of oncology

Providing quality improvement tools and services for medical practices in the field of clinical oncology; medical consultancy regarding patient care for the purpose of quality improvement services, namely, assessment program for oncology practices for purposes of documenting concordance with quality measures, implementing best practices, and documenting improvement; scientific and medical research, namely, collecting, analyzing, and validating medical and clinical healthcare quality data and preparing reports in connection therewith in the field of cancer care and treatment
asco certified

General Information


Serial Number98711524
Word MarkASCO CERTIFIED
Filing DateThursday, August 22, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, March 5, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkAMERICAN SOCIETY OF CLINICAL ONCOLOGY CERTIFIED
Goods and ServicesBusiness advisory services, consultancy, and information in the nature of quality improvement services, namely, assessment program for oncology practices for purposes of documenting concordance with quality measures, implementing best practices, and documenting improvement; business information services in the field of oncology
Goods and ServicesProviding quality improvement tools and services for medical practices in the field of clinical oncology; medical consultancy regarding patient care for the purpose of quality improvement services, namely, assessment program for oncology practices for purposes of documenting concordance with quality measures, implementing best practices, and documenting improvement; scientific and medical research, namely, collecting, analyzing, and validating medical and clinical healthcare quality data and preparing reports in connection therewith in the field of cancer care and treatment

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, August 22, 2024
Primary Code035
First Use Anywhere DateFriday, May 31, 2024
First Use In Commerce DateFriday, May 31, 2024

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 22, 2024
Primary Code044
First Use Anywhere DateFriday, May 31, 2024
First Use In Commerce DateFriday, May 31, 2024

Trademark Owner History


Party NameAmerican Society of Clinical Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAlexandria, VA 22314

Trademark Events


Event DateEvent Description
Thursday, August 22, 2024NEW APPLICATION ENTERED
Thursday, February 27, 2025ASSIGNED TO EXAMINER
Friday, January 17, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 5, 2025NON-FINAL ACTION E-MAILED
Wednesday, March 5, 2025NON-FINAL ACTION WRITTEN
Wednesday, March 5, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED